American Oriental Bioengineering, Inc.

AOBI · OTC
Analyze with AI
9/30/2013
6/30/2013
3/31/2013
12/31/2012
Operating Activities
Net Income-$21-$13-$21-$36
Dep. & Amort.$3$3$3$3
Deferred Tax$0$1$0$1
Stock-Based Comp.$0$0$1$1
Change in WC-$2$7$13-$17
Other Non-Cash$3-$1$3$39
Operating Cash Flow-$17-$3-$2-$9
Investing Activities
PP&E Inv.-$14-$1-$0-$13
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0$4$3
Investing Cash Flow-$13-$1$4-$11
Financing Activities
Debt Repay.$28$2-$5$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2$1$3$1
Financing Cash Flow$26$3-$2$1
Forex Effect$1$2-$1-$0
Net Chg. in Cash-$4$1-$1-$19
Supplemental Information
Beg. Cash$7$6$7$26
End Cash$3$7$6$7
Free Cash Flow-$31-$4-$2-$23